Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference | ATHE Stock NewsStockTitan·Oct 9, 2026 at 03:05 AMATHE+1.30%
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga_article·Oct 2, 2026 at 12:05 PMATHE+1.30%BDMD-3.80%
Alterity Therapeutics Sets 2026 AGM Date and Director Nomination DeadlineTip Ranks·Sep 25, 2026 at 03:57 AMATHE+1.30%
Insider Move at Biotech Firm Sparks Fresh Investor InterestTip Ranks·Sep 9, 2026 at 02:08 AMATHE+1.30%
Alterity Therapeutics director Peter Ashley Marks acquires 47,620 shares for $0.50 each, valued at $23,810PUBT·Sep 8, 2026 at 11:02 PMATHE+1.30%
Alterity Therapeutics issues 8,400,000 shares tied to exercised options at A$ 0.5 eachPUBT·Sep 8, 2026 at 10:04 AMATHE+1.30%
Alterity Therapeutics Issues 8.4 Million Shares Under Underwriting DealTip Ranks·Sep 8, 2026 at 02:07 AMATHE+1.30%
